We examined the distribution of glycoprotein Ub-Ila (GPIIb-IIIa) and its ligands fibrinogen and von Willebrand factor (vWf) on platelets which had adhered under flow conditions. Immunoelectron microscopy was performed on whole mounts and frozen thin sections of adhering platelets. GPIIb-Il~a was homogeneously distributed on dendritic platelets and on interplatelet membranes of formed thrombi. Fibrinogen and vWf were predominantly associated with interplatelet membranes and membranes facing the substrate. On whole mounts, vWf appeared in clumps and linear arrays, representing the tangled or extended forms of the multimeric molecule. From semiquantitative analysis, it appeared that fibrinogen and vWf were, respectively, nine-and fourfold higher on interplatelet membranes than on surface membranes facing the blood stream, while GPIlb-Ia was evenly distributed over all platelet plasma membranes. Ligand-induced binding sites (LIBS) of GPIIbMIIa, as measured with conformation specific monoclonal antibodies RUU 2.41 and LIBS-1, were present on the surface of adhered platelets and thrombi. A redistribution of LIBS-positive forms of GPIMh-Ma towards interplatelet membranes was not observed. Our data support the hypothesis that, under flow conditions, ligands have first bound to activated GPIIb-IIIa but this binding is reversed on the upper surface of adhering platelets. This relative absence of ligands on the exposed surface of thrombi may play a role in limiting their size. (J. Clin. Invest. 1994Invest. . 94:1098Invest. -1112 
Introduction
At sites of vascular injury, platelets undergo a complex series of biochemical and morphological events, essential for normal hemostasis. Adhesion of platelets to the damaged vessel wall is the first step in this series of events ( 1-3 ). Platelet activation and aggregation occur after adhesion to the exposed subendothelium (4) . All these processes are mediated by specific mem-brane glycoproteins on the platelet surface and their ligands. Glycoprotein Ib and vWf are particularly involved in the initial attachment of platelets to the vessel wall (2, 5, 6) , and it has become evident that GPIIb-IIIa also participates in platelet adhesion (7) . Plasma vWf does not bind to nonactivated circulating platelets, but adhesion of platelets to subendothelium strongly depends on vWf bound to it (5) . Besides playing a role in platelet adhesion, vWf is also involved in platelet-platelet interaction, particularly at high shear rate through interaction with GPIIb-Ia (8, 9) . Platelet membrane GPIIb-IIIa is the major receptor for fibrinogen, vWf, fibronectin, and vitronectin and is essential for platelet aggregation ( 10, 11) . In response to physiological agonists such as ADP or thrombin, platelets bind circulating fibrinogen via exposed GPIIb-llIa on the membrane of activated platelets (12) (13) (14) (15) . The distribution of platelet membrane GPHb-IIIa on resting and stimulated platelets as well as on platelets spread on a surface has been the subject of several studies using a variety of approaches (16) (17) (18) (19) (20) (21) (22) . WencelDrake (16) reported cycling of GPIIb-IIIa between a-granules and the plasma membrane, when platelets were incubated with specific monoclonal antibodies. Local redistribution events in terms of GPIIb-IIIa clustering were described after agonist stimulation of platelets in suspension (17) . Agonist stimulation in suspension resulted in accumulation of fibrinogen-gold in channels of the open canalicular system (OCS)' ( 19) . Translocation of GPIIb-IIIa towards platelet centers and accumulation in channels of the OCS was observed when surface-spread platelets were incubated with fibrinogen-gold (20) (21) (22) (23) . Such a redistribution of GPIIb-IIIa, however, was not found when platelets were fixed before immunolabeling (24) . These studies on receptor distribution using activation by surfaces or agonists, followed by ligand binding, were all performed under static conditions. Moreover, several of these studies were performed on platelets that were fully spread on nonphysiological surfaces. Perfusion experiments in our laboratory have shown that the ability of platelets to form either a monolayer or aggregates strongly depends on the surface and shear rate (25) . Redistribution of GPIIb-IIa after adhesion may be an important condition for formation of platelet aggregates. In addition, exposure of internal receptor pools and/or microenvironmental changes of GPIIb-Illa upon platelet activation may result in secondary platelet responses (26) (27) (28) .
Here we study the receptor distribution and the association of ligands under flow conditions. Immunoelectron microscopy was performed on whole mounts and frozen thin sections of platelets that had adhered to type I collagen and matrices of human endothelial cells and fibroblasts after perfusion with whole blood. The surface expression as well as interplatelet localization and polarity were studied after preembedding and postembedding labeling and ultra-thin cryosectioning of adhering platelets. GPIIb-IIIa was distributed homogeneously on membranes of adhering dendritic platelets and on platelets in thrombi formed during perfusion. In contrast, ligands associated with GPIIb-IIIa were concentrated between platelets at the sites of interplatelet contact, with a conspicuous absence on the exposed upper surface of the platelets. Table I . Rabbit polyclonal anti-GPIIb was from our own department. It stained only the GPIIb band in Western blots of SDS-PAGE of whole platelets and it showed no staining with platelets of a patient with Glanzmann thrombasthenia. Rabbit polyclonal antiGPIIb-llIa and polyclonal anti-P-selectin (GMP140) were a gift from Dr. M. C. Berndt (Baker Medical Research Institute, Prahran, Victoria, Australia) and were described previously (29) . Monoclonal antibody C17, directed to GPIIIa was a kind gift from Dr. A. von dem Borne (CLB Biotechnology, Amsterdam, The Netherlands) (30) . To detect conformational changes in the GPIIb-IIIa complex that occur during platelet adhesion and aggregation under flow two activation-dependent monoclonal antibodies were used. mAb RUU SP 2.41 was developed in our own department according to standard procedures as described previously (31 ) . Briefly, mice were immunized with paraformaldehydefixed thrombin-activated platelets. The IgG-containing fraction was obtained by affinity chromatography on a protein A-agarose column. The antibody (IgGI) does not react with resting platelets and binds to ADP or thrombin-activated platelets in the presence of fibrinogen or fibronectin as studied with FACS® analysis. mAb 2.41 binds to 21,000 sites on thrombin-stimulated platelets. The antibody does not react with activated Glanzmann platelets, suggesting that 2.41 reacts with an epitope on GPIIb-IIIa, an epitope which is exposed on the surface of the platelet after a conformational change in the complex has occurred through the binding of fibrinogen (Metzelaar, M., H. K. Nieuwenhuis, and J. J. Sixma, unpublished data (32, 33) . Polyclonal anti-human vWf antiserum was raised in rabbits as described previously (34 Absence of Ligands on GPIIb-IIa on the Upper Membranes of a Thrombus then prepared for ultra-thin cryosectioning followed by postimmunostaining. Immunolabeling on whole mounts was performed on 50-1il drops on parafilm. The coverslips with adhered platelets facing downwards were transferred to the antibody drops, incubated for 60 min, and rinsed with PBS plus 0.1% BSA. The antibodies were visualized using protein A-gold markers prepared according to the method of Slot et al. (39) . Control incubations were carried out on nonperfused matrices using polyclonal antifibrinogen and anti-vWf antibody in combination with protein A-gold or alternatively with protein A-gold alone to check for the presence of ligand or IgG in the matrices before perfusion. For whole mount evaluation, the coverslips were fixed in 1% glutaraldehyde in 0.1 M phosphate buffer, and were rinsed and postfixed in 1% OS04 for 30 min. Samples were dehydrated through a graded series of ethanol to absolute ethanol and finally dried in a critical point device (CPD 010; Balzers Aktiengesellschaft, Liechtenstein). The dried samples were stabilized with carbon evaporation and carefully cut into small squares with a razor blade. Coverslips were placed cell-side-up on a drop of 0.4% hydrofluoric acid in a small Petri dish (30 mm), and within 2-5 min the melamine foil separated from the glass coverslip. The hydrofluoric acid solution was replaced by distilled water, and the foils were mounted on electron microscopy grids. The whole mount preparations were examined in a JEOL 1200EX electron microscope, at 120 kV. A 12°tilting angle was used to produce stereo-paired electron micrographs.
Ultra-thin cryosectioning. For ultra-thin cryosectioning, fixed coverslips were rinsed three times with PBS, followed by a 10-min incubation in PBS containing 5% gelatin at 370C. The backside of the coverslips was dried, and enough gelatin was removed from the upper surface to leave a thin layer. The coverslips were then placed on ice to solidify the gelatin layer. Removal of the melamine foil with adhered platelets from the glass coverslips was now carried out with the aid of 0.8% hydrofluoric acid, at 40C. Because of the gelatin layer, a higher hydrofluoric acid concentration and a longer separation time were needed. The separation of the foil from the glass coverslip took generally 15-20 min. The hydrofluoric acid solution was replaced by distilled water, and the foil was picked up with a pair of tweezers and transferred to a 10% gelatin in PBS at 37°C. The reason for this was to maintain the foils with adhering platelets in a gelatin environment. The foils with adhering platelets were centrifuged carefully, and the gelatin was solidified at 4°C. Small gelatin blocks were then cut from the pellet, immersed in 2.3 M sucrose at 4°C, and frozen in liquid nitrogen. Ultrathin cryosectioning was performed on a Reichert FC 4E and Ultracut S microtome (Leica Aktiengesellschaft, Reichert Division, Vienna, Austria) and immunogold labeling was performed according to the method of Tokuyasu as adapted by Slot et al. (40) . Specificity of the immunolabeling was verified using a control antibody directed against amylase and protein A-gold or protein A-gold alone. In the case of monoclonal antibody RUU SP 2.41 and LIBS-1, we used rabbit anti-mouse IgG as an intermediate step. Immunolabeling was also performed on ultra-thin cryosections of freshly fixed platelets, obtained from platelet-rich plasma samples before perfusion, or from platelets, obtained from blood directly collected into fixative. The relative distribution of GPIb-IIIa, vWf, and fibrinogen on platelets that adhered to type I collagen was analyzed in comparative single and double labeling experiments using different gold markers. Semiquantitative analysis of immunogold labeling was performed on electron micrographs that were randomly selected at low magnification. Platelet membranes were divided into upper thrombus membranes, interplatelet membranes, and platelet surface interfaces. Gold particles were attributed to the upper surface when no adjacent membranes were present. A lattice was used on the same electron micrographs to estimate the membrane surface area. Label densities were obtained by dividing the relative number of gold particles by the relative number of membrane intersections. The label was expressed as a percentage of the total label.
Results
The use of melamine-coated substrates gave us the unique possibility to evaluate platelet coverage at the light microscopy level and at the same time to study the surface distribution of membrane glycoproteins and ligands on whole mount preparations at the electron microscopy level. Moreover, the melamine foils were very suitable to study interplatelet and platelet substrate interactions on frozen thin sections.
Whole mount evaluation General observations. No platelet adhesion was observed when melamine foils, blocked with 1% human serum albumin, were exposed to flowing blood. Platelet adhesion to melamine foils coated with collagen type I or with the matrix of endothelial cells or fibroblasts was similar to adhesion to the same substrate directly coated to glass (Table II) . Platelet adhesion after 5 min of perfusion over endothelial cell matrix is illustrated in Fig. 1 a. Dendritic and more extensively spread platelets had attached to the endothelial cell matrix. Fig. 1 Immunolocalization of fibrinogen and vWf. Fig. 2 also shows immunogold staining after postembedding double immunolabeling of fibrinogen and vWf (10 and 5 nm gold, respectively). Label is present at interplatelet membranes, although many platelet contact sites showed no labeling. Fibrinogen and vWf were also abundantly present in large intracellular vacuoles and in a-granules. The upper surface membranes of aggregates facing the blood stream had a much lower labeling intensity than the interplatelet membranes (Figs. 2 and 3 ). Contact and dendritic platelets showed a similar intracellular labeling of both ligands in a-granules and in vacuoles of the OCS. Binding of vWf and fibrinogen was also restricted mainly to the lateral membranes of adjacent contact platelets and not to the upper surface (Figs. 3 d and 4) . The typical linear distribution that we observed in whole mounts after immunolabeling for vWf was occasionally observed in thin sections also (Fig. 3 b) . To extend our findings concerning the association of both ligands at interplatelet membranes, we performed double immunolabeling. vWf and fibrinogen colocalized at the same interplatelet areas and sometimes in large intracellular vacuoles (Fig. 3 d) . However, some interplatelet contact sites contained only fibrinogen (Fig. 3 c) , while also interplatelet contact sites were observed that lacked both ligands. To exclude the possibility that GPIIbIla is occupied by fibronectin or vitronectin, we performed control experiments using antifibronectin and antivitronectin antibodies. Fibronectin and to a lower extent vitronectin were both strongly associated with the type I collagen surface after perfusion. Platelet-associated and intracellular labeling was observed at low densities at interplatelet membranes and in agranules, fibronectin being slightly more abundant than vitronectin (results not shown).
Immunolabeling ofmatrices. Our findings on whole mounts of fibroblast matrices were confirmed in frozen thin sections. Matrices of endothelial cells and type I collagen substrates revealed vWf labeling. Perfusion over fibroblast matrix and subsequent immunolabeling of vWf and fibrinogen revealed no labeling at sites in the matrix where no platelets adhered. At the interface between adhered platelets and fibroblast matrix, however, both ligands were found localized in a similar intensity as at interplatelet sites. An example of two contact platelets adhering to a fibroblast matrix is given in Fig. 4 after double immunolabeling of vWf and fibrinogen. Lateral contacts and basal contacts show labeling of both ligands.
Immunolocalization of GPIIb-IIIa. Immunolocalization of GPIIb-IIIa using a polyclonal anti-GPIIb-IIIa antibody and protein A-gold is shown in Fig. 5 . Gold particles were distributed evenly on the upper surface membranes of small aggregates and at interplatelet membranes (Fig. 5 a) . Membranes of agranules and of the OCS also exhibited specific GPIlb-IIla labeling. Membranes of contact and dendritic platelets exhibited a similar extensive GPIIb-IIIa labeling (Fig. 5 b) . A similar distribution was obtained when an anti-GPIIIa mAb (C17) or a polyclonal anti-GPilb antibody was used (not shown).
Activation-dependent and ligand-occupied GPIIb-IIIa. In an attempt to follow the conformational state of the receptor, we used mAbs LIBS-1 and RUU SP 2.41, which selectively recognize ligand-occupied forms of GPIlb-HIa. Immunolabeling performed on frozen thin sections using LIBS-1 and RUU SP 2.41 mAbs resulted in a specific surface expression on adhering platelets and platelet aggregates. Interplatelet membranes were also frequently labeled (Fig. 6) . The amount of surface labeling was low for RUU SP 2.41 and moderate for the LIBS-1 antibody. The gold particles were also associated with platelet pseudopodes (Fig. 6, inset) .
Semiquantitative data. A semiquantitative comparison of gold particle distribution on upper thrombus surface versus interplatelet membranes is shown in Table Ill . A significantly higher fibrinogen and vWf concentration is apparent at interplatelet membranes (P < 0.05). Of interest, the quantitative data of the GPIlb-HIa distribution indicated a somewhat higher expression on the upper surface than on interplatelet membranes. The data for the receptor distribution were obtained both after immunolabeling with a polyclonal anti-GPilb antibody and an anti-GPIIb-iIIa antibody. Quantitative analysis of the LIBS-positive forms of GPIlb-Ia also showed a higher expression on the upper surface than on interplatelet contact sites. To obtain an optimal surface labeling of both GPIlb-HIa and fibrinogen/vWf, we also performed preembedding labeling followed by cryosectioning. Double immunolabeling was performed using mAb LIBS-1 as the first antibody (PAG10) and rabbit antifibrinogen as the second antibody (PAG15). Then, after embedding and subsequent cryosectioning, a third immunolabeling step was performed using either antifibrinogen or anti-vWf (PAG5). Fig. 7 shows an example of such a triple labeling. Again surface expression of LIBS-positive receptors was apparent on the upper surface of adhering platelets and platelet aggregates. Occasionally some fibrinogen labeling was observed on the upper surface (Fig. 7, double arrowhead) , but the association with these upper membranes was not increased in these preparations compared with the postembedding staining. The close apposition of platelet contacts excluded antibodies and immunogold probes from most interplatelet sites, but occasionally labeling after preembedding staining was observed associated with interplatelet membranes in these preparations (Fig. 7, arrowhead) . The subsequent postembedding labeling revealed again labeling at the interplatelet sites (Fig. 7, arrows) .
Control immunolocalization experiments. In control experiments, using directly fixed washed platelets, immunogold localization of vWf and fibrinogen was restricted to a-granules. None of the ligands were found associated with the plasma membrane. Surface expression was negligible when platelets obtained from blood directly collected into fixative were immunolabeled with LIBS-1 or RUU SP 2.41. The adhesion of platelets under flow conditions was accompanied by surface expression of P-selectin (GMP 140), indicating that membranes of a-granules had fused with the platelet plasma membrane and with membranes of the OCS. Expression of P-selectin was observed on the upper surface of thrombi and on single adhering platelets (Fig. 8) . Additional evidence for platelet secretion was obtained after immunolabeling for thrombospondin. Intracellular vacuoles of the OCS, and to a lower extent interplatelet contact sites, were labeled with thrombospondin. No surface labeling was observed (Fig. 9) . Parallel immunolabeling experiments were also performed for immunolocalization of GPIb. The surface distribution of GPIb was random over all membranes, and no clustering was observed (not shown). 
Discussion
In this study, immunoelectron microscopy was used to investigate the surface distribution of GPIIb-IIIa, and fibrinogen and vWf under flow conditions. Whole mount incubation was followed either by en face evaluation or cross-sectioning. Alternatively, ultra-thin cryosectioning and subsequent immunogold labeling were performed on adhered platelets and small aggregates to study platelet contact events.
En face evaluation of immunolabeled whole mounts was only possible at matrices and electron-lucent margins of adhered platelets and provided additional evidence for a three-dimensional vWf distribution. In thin frozen sections, GPIIb-IIIa appeared evenly distributed on interplatelet membranes and at the upper surfaces of small aggregates. Contact and dendritic platelets showed a similar random GPIlb-IIIa distribution. Our morphological observations suggest that the GPILb-IIIa complex is not clustered on the platelet surface during initial platelet 1104 Heynen et al. adhesion in flow, but apparently remains evenly distributed over the platelet surface. Moreover, when aggregates were formed in flow, no polarity was observed in the GPIIb-Ila distribution.
Surface activation and stimulation by agonists in general results in centralization of platelet a-granules. Simultaneously, released a-granule contents may be expressed on the platelet surface. The observed central localization of vWf and fibrinogen that was observed on whole mounts of fully spread platelets may therefore be the result of release of these ligands from a-granules during adhesion to the surface. Reorganization of GPIIbII1a in terms of receptor clustering as described by Isenberg (12) was not observed in our whole mounts. Local redistribution events at sites that are not visualized in whole mounts (i.e., cell bodies of dendritic platelets and interplatelet membranes) are not resolved in thin frozen sections and therefore may still occur.
In agreement with previous studies, we showed that vWf also participates in platelet-platelet interaction under flow conditions. The linear arrays of gold particles that were observed after immunolabeling of vWf probably represent large vWf multimers that connect adjacent platelets and platelets with matrix. Electron microscopic visualization of vWf substructure with rotary shadowing has shown tangled and extended conformations (41, 42) . In extended form, the vWf multimers may reach lengths that exceed the diameter of platelets. Since a polyclonal antibody was used in our studies, presumably reacting with several repetitive epitopes, the observed linear gold pattern most likely reflects the extended conformations of vWf. Such extended conformations may form multiple interplatelet contacts via GPIIb-IIla, thereby reinforcing the platelet-platelet interaction. We also demonstrate colocalization of fibrinogen and vWf at interplatelet contact sites, indicating that both may act as bridging molecules between adjacent platelets. Our ultrastructural results show that large vWf multimers are capable of connecting long interplatelet distances, while in some instances fibrinogen is observed at closer platelet contacts. Whether fibrinogen acts as the short distance molecular bridge and vWf as the long distance molecular bridge, or whether they bind Lw'mm At ; -Patti"''. Aa Figure 5 . Immunolabelmng of GPIIb-HIIa using a polyclonal anti GPLIb IIla antibody followed by PAGlO. Surface expression and interplatelet distribution of total GPIIb-HIa and LIBS-positive forms of the receptor are given. Label density is the ratio of gold label and number of membrane intersections and is expressed as a percentage of the total density. * Statistically significant. * The large differences in receptor distribution are discussed in the text.
cooperatively, remains unclear. Parker et al. (9) showed that GPIIb-Illa is an important receptor for platelet vWf, and competition of vWf with fibrinogen for binding to GPI~h-IIIa was shown by Pietu et al. (8) . (45) postulated that tight packing of bound fibrinogen may form an adequate adhesive surface for nonactivated circulating platelets. In this context it is of importance to mention recent studies on the adhesion of nonactivated platelets to solid phase fibrinogen (46, 47) and the fibrinogen mediated interaction of cells exposing nonactivated GPIIb-Ila with already existing aggregates (48) . In our perfusion model, a minimal number of bound ligand molecules may be required to 1110 generate such an "adhesive" surface for newly arriving circulating platelets. The relative absence of ligands on the upper surface of adhering platelets or thrombi may thus have important consequences for aggregate formation. The absence of ligands which we observe here has been postulated in literature as a cause for the formation of a single monolayer of platelets when subendothelium was exposed to flowing blood in experimental animals (49) . Our observations are in agreement with this.
Lewis et al. (50) also found a discrepancy between localization of GPIlb-IIla and fibrinogen-gold binding to surface-spread platelets. Similar data were reported by Kieffer et al. (51) who used surface-spread platelets, incubated at 40C with antibodies to GPIIb-HIa, fibrinogen, and vWf. Heilmann et al. (52) described ubiquitous presence of GPIlb-IIIa and local absence of fibrinogen under aggregating conditions. The experimental design of our present studies, however, is basically different. Our perfusion experiments were designed to study the GPIIbIla distribution under flow conditions, whereas the published studies were carried out under static conditions. Secondly, in our perfusion experiments, adhered platelets were fixed before incubation with specific antibodies.
The interaction of vWf with fibrillar type I collagen has been described previously (53) . Interaction of fibrinogen with type I collagen, which was observed here, was not expected and may play a role in the platelet-substrate interaction. The origin of fibrinogen and vWf at the interface of adhered platelets and fibroblast matrix remains unclear. In a perfusion experiment using platelets reconstituted in human albumin solution, we observed vWf and fibrinogen in large vacuoles at close proximity to the basal platelet membrane, suggesting release towards the basal interface (not shown). This local polar release of endogenous fibrinogen and vWf may then contribute to the spreading of the platelet.
In this study we have shown the preferential localization of fibrinogen and vWf between and below platelets, whereas GPHb-Ia itself and LIBS-positive forms of the receptor are distributed evenly over all membranes. Therefore we hypothesize that the binding of vWf and fibrinogen to GPIIb-iIa is reversible on the upper surface of adhering platelets under flow. We believe that the decreased association of fibrinogen and vWf with the upper surface of thrombi may limit thrombus growth under flow conditions. The cause of this phenomenon is still unknown and deserves further investigation.
